Icahn accuses Forest of hiding poison pill pacts

Activist investor Carl Icahn, engaged in a bitter proxy battle with Forest Laboratories, accused the drugmaker of hiding information from shareholders that might show it has provisions built into its licensing agreements that would deter a potential suitor. Icahn said on Friday he had asked a Delaware court to allow him to release non-public information to shareholders.

Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus